In 1999, the US Food and Drug Administration (FDA) approved rofecoxib (Vioxx) for the treatment of acute pain and the pain associated with osteoarthritis. Its manufacturer, Merck, marketed the drug...
from Latest headlines from BMJ http://ift.tt/2Fg7ZSr
via
IFTTT
No comments:
Post a Comment